All issues
Volume 119 (2002)
- Issue 6 Pages 319-
- Issue 5 Pages 273-
- Issue 4 Pages 201-
- Issue 3 Pages 135-
- Issue 2 Pages 65-
- Issue 1 Pages 7-
Volume 119, Issue 3
Displaying 1-7 of 7 articles from this issue
- |<
- <
- 1
- >
- >|
Award Lecture
-
Yutaka KOYAMAArticle type: Award Lecture
2002 Volume 119 Issue 3 Pages 135-143
Published: 2002
Released on J-STAGE: December 24, 2002
JOURNAL FREE ACCESSA phenotypic alteration of astroglia, “astroglial activation”, is a common phenomenon observed on brain pathologies. The hypertrophy/hyperplasia of activated astroglia causes a glial scar, which prevents synaptic re-generation. In contrast, many neurotrophic substances are produced by the activated astroglia. Thus, the functional alteration of astroglia is important in tissue repair processes of the damaged CNS. Endothelins (ETs) are involved in the pathophysiological responses of the CNS. We found that injection of ETs into rat brain induced activated astroglia. A selective ETB-receptor antagonist attenuated the induction of activated astroglia. In cultured astroglia, ETs reproduce the functional alterations characterizing activated astroglia; i.e., increases in proliferation, morphological changes and stimulation of several gene transcriptions. ETs re-organized astroglial cytoskeletal actin through a small GTP-binding protein, rho, which may underlie the astroglial hypertrophy. Analysis of gene expression showed that transcriptions of neurotrophic factors (GDNF and BDNF) were stimulated by ETs. ETs stimulated astroglial proliferation by both adhesion-dependent and -independent mechanisms, where FAK and ERK plays key roles, respectively. These findings suggest important roles of ETs in the regulation of astroglial functions.
View full abstractDownload PDF (133K) -
Tatsuya SAWAMURAArticle type: Award Lecture
2002 Volume 119 Issue 3 Pages 145-154
Published: 2002
Released on J-STAGE: December 24, 2002
JOURNAL FREE ACCESSRecent progress in the study of atherosclerosis revealed that the proatherogenic property of LDL is attributable to oxidized LDL. Macrophages recruited to vascular wall phagocytose oxidized LDL and transformed into foam cells, which is a hallmark of atheroma. Endothelial cells also binds oxidized LDL and changes its phenotype to the status of “endothelial dysfunction.” We successfully cloned the endothelial receptor for oxidized LDL, designated LOX-1. LOX-1-mediated action of oxidized LDL induces the decrease in NO release and the increased expression of adhesion molecules, which are typical changes in endothelial dysfunction. The expression of LOX-1 is quite inducible. Proinflammatory cytokines, etc. induce the expression of LOX-1 in vitro; and proatherogenic conditions, e.g., hypertension, hyperlipidemia, and diabetes, induce the expression of LOX-1 in vivo. This manner of expression suggests the importance of LOX-1 in pathological settings. LOX-1 binds not only oxidized LDL, but also binds apoptotic cells and activated platelets through the interaction with anionic phospholipids. This property might bridge atherosclerosis and thrombosis. A novel system to detect LOX-1 ligand in plasma detected the increased level of LOX-1 ligand in hypercholesterolemic rabbits compared with normal ones. This system might be useful to predict the status of endothelial function and the risk of ischemic heart disease.
View full abstractDownload PDF (215K) -
Functional analysis of calcineurin-mediated signalling pathway using fission yeast as a model systemReiko SUGIURAArticle type: Award Lecture
2002 Volume 119 Issue 3 Pages 155-161
Published: 2002
Released on J-STAGE: December 24, 2002
JOURNAL FREE ACCESSCalcineurin (CN), a highly conserved Ca2+/calmodulin-regulated phosphatase, is a critical component of many calcium-regulated processes in mammalian cells, including T cell activation, cardiac hypertrophy, learning and memory. CN is specifically inhibited by the immunosuppressant drugs cyclosporin A and tacrolimus (FK506), and these drugs have served as valuable reagents in identifying the role of CN in a wide variety of cell types. CN may have additional functions in other cell types, and the loss of these functions may contribute to the side effects of these drugs, which include nephrotoxicity and neurotoxicity. A better understanding of the biological roles of CN in different cell types may promote the development of improved strategies for immunosuppression. We have been studying the CN signal transduction pathway in fission yeast because this system is amenable to genetics and has many advantages in terms of relevance to higher systems. Fission yeast has a single gene encoding the catalytic subunit of CN, ppb1+, that is essential for cytokinesis. We have shown that in fission yeast CN plays an essential role in maintaining chloride ion homeostasis and acts antagonistically with the Pmk1 MAP kinase pathway. We also carried out an isolation and a screening for several FK506-sensitive mutants in order to identify genes that share an essential function for viability with CN. Possible roles of these gene products in cellular functions in relation to calcineurin are discussed.
View full abstractDownload PDF (109K)
Technical Note
-
Hidekazu TANAKAArticle type: Technical Note
2002 Volume 119 Issue 3 Pages 163-166
Published: 2002
Released on J-STAGE: December 24, 2002
JOURNAL FREE ACCESSThe procedure for making a low density culture of hippocampal neurons has been elaborated by Goslin and Banker. The viability of hippocampal neurons, which are sparsely disseminated on the glass surface, is maintained by a separately cultured glial monolayer; the glial feeder layer is grown on the bottom surface of the dish, while those neurons, placed face down, are attached on the coverslips. This method is originaly designed for the observation of the maturation, polarity and axogenesis of a single neuron. In addition, this method can be applied for a variety of other purposes: (1) to observe synaptogenesis, (2) to analyze synaptic function electrophysiologically, (3) to analyze receptor functions and signaling cascades pharmacologically, (4) to visualize a molecular dynamics by time-lapse analyses of GFP-tagged molecules, and (5) to observe ultrastructure by an electron microscope. Furthermore, these neurons are useful even in biochemical experiments because they are relatively uniform without glial contamination and highly enriched in synaptic components.
View full abstractDownload PDF (39K)
Review on New Drug
-
Susumu OTOMOArticle type: Review on New Drug
2002 Volume 119 Issue 3 Pages 167-174
Published: 2002
Released on J-STAGE: December 24, 2002
JOURNAL FREE ACCESSThe length and size of hair are depend on the anagen term in its hair cycle. It has been reported that the some cell growth factors, such as VEGF, FGF-5S, IGF-1 and KGF, induce the proliferation of cells in the matrix, dermal papilla and dermal papillary vascular system and increase the amount of extra cellular matrix in dermal papilla and then maintain follicles in the anagen phase. On the other hand, negative factors, like FGF-5, thrombospondin, or still unknown ones, terminate the anagen phase. If the negative factors become dominant against cell proliferation factors according to fulfilling some time set by the biological clock for hair follicles, TGFβ induced in the matrix tissues evokes apoptosis of matrix cells and shifts the follicles from anagen to catagen. Androgenetic alopecia is caused by miniaturizing of hair follicles located in the frontal or crown part of scalp and are hereditarily more sensitive to androgen. In their hair cycles, the androgen shortens the anagen phase of follicles and shifts them to the catagen phase earlier than usual. The mode of action of hair growth effect of minoxidil is not completely elucidated, but the most plausible explanation proposed here is that minoxidil works as a sulfonylurea receptor (SUR) activator and prolongs the anagen phase of hair follicles in the following manner: minoxidil (1) induces cell growth factors such as VEGF, HGF, IGF-1 and potentiates HGF and IGF-1 actions by the activation of uncoupled SUR on the plasma membrane of dermal papilla cells, (2) inhibits of TGFβ induced apoptosis of hair matrix cells by opening the Kir 6.0 channel pore coupled with SUR on the mitochondrial inner membrane, and (3) dilates hair follicle arteries and increases blood flow in dermal papilla by opening the Kir 6.0 channel pore coupled with SUR on the plasma membrane of vascular smooth muscle cells.
View full abstractDownload PDF (95K) -
Megumi AKIYOSHI, Tsunehiko SHIGEOKA, Shinichi TORII, Eiji MAKI, Satoru ...Article type: Review on New Drug
2002 Volume 119 Issue 3 Pages 175-184
Published: 2002
Released on J-STAGE: December 24, 2002
JOURNAL FREE ACCESSLevocabastine is a selective histamine H1-receptor antagonist exerting inhibitory effects on the release of chemical mediators from mast cells and on the chemotaxis of polymorphonuclear leukocytes and eosinophils. Both histamine and antigens induced conjunctivitis was inhibited by levocabastine in several allergy models. Levocabastine moderately inhibited histamine-release from guinea pig conjunctive induced by antigen-antibody reactions and prevented an increase in the vascular permeability of the conjunctive elicited by both histamine and antigen instillation. Symptoms of allergic rhinitis, which were induced by histamine, substance P and antigen, were also reduced by levocabastine. Levocabastine prevented an increase in the vascular permeability of nasal mucosa elicited by instillation of these three inducers. Furthermore, levocabastine has shown a large difference between the antiallergic dose and other non-specific pharmacological effective dose than that with other antiallergic drugs. The non-specific pharmacological effect of levocabastine reveals only blepharoptosis. With these pharmacological effects and topical usage, levocabastine was shown to be useful for allergic conjunctive and rhinitis in both seasonal and perennial clinical use.
View full abstractDownload PDF (157K) -
Yuji IWANAGAArticle type: Review on New Drug
2002 Volume 119 Issue 3 Pages 185-190
Published: 2002
Released on J-STAGE: December 24, 2002
JOURNAL FREE ACCESSIrritable bowel syndrome (IBS) is a functional bowel disorder characterized by abdominal pain or discomfort and abnormal defecation. Polycarbophil calcium, a water-absorbing polymer, is expected to improve stool consistency. Polycarbophil calcium decalcified under the acidic condition and then absorbed 70 times its weight of water under the neutral condition. In in situ experiments using rat jejunum and colon, polycarbophil decreased water absorption by the intestine without affecting water secretion. Polycarbophil inhibited prostaglandin E2-, 5-hydroxy-L-tryptophan- and castor oil-induced diarrhea in mice or rats. Polycarbophil calcium also inhibited sennoside-induced diarrhea in dogs. Polycarbophil increased the weight of feces in naive or low-fiber diet feeding rats. In naive dogs, polycarbophil calcium increased stool frequency, stool weight and moisture. Polycarbophil was not absorbed from the gastrointestine, not metabolized and eliminated into feces in rats and dogs. Polycarbophil calcium did not affect the absorption of co-administered drugs in dogs. In the dose-finding clinical study for IBS, polycarbophil calcium was effective both in diarrhea and constipation. In the Phase III study, polycarbophil calcium was superior to trimebutine maleate in efficacy and equal in safety. Emesis/vomiting and thirst were observed, but episodes of diarrhea or constipation by excessive action were few. Polycarbophil calcium seems promising as an anti-IBS agent.
View full abstractDownload PDF (110K)
- |<
- <
- 1
- >
- >|